Your session is about to expire
← Back to Search
Robotics
Seated Ankle Robot Training for Foot Drop
N/A
Waitlist Available
Led By Charlene E. Hafer-Macko, M.D.
Research Sponsored by Baltimore VA Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Chronic foot drop and ankle weakness in one leg from a peripheral nervous system injury due to a neuromuscular or orthopedic injury
Be older than 18 years old
Must not have
Active deep venous thrombosis
Distal paretic leg skin lesions, infections, or soft tissue inflammation
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to: post-6 weeks of training, and 6 weeks after completion of training
Awards & highlights
No Placebo-Only Group
Summary
This trial will test if an ankle robot can help people with ankle weakness and foot drop from a peripheral nervous system injury.
Who is the study for?
This trial is for men and women aged 18 to 88 with chronic foot drop and ankle weakness in one leg due to neuromuscular or orthopedic injuries. Participants must be able to walk 10 meters and get up from a chair without help, though they can use assistive devices.
What is being tested?
The study is testing the effectiveness of a seated ankle robot training program designed for people suffering from foot drop as a result of peripheral nervous system injuries.
What are the potential side effects?
While not explicitly listed, potential side effects may include discomfort at the site of robotic assistance, muscle soreness, fatigue from exercise, or skin irritation around the affected area.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have chronic foot drop and ankle weakness in one leg due to a nerve or muscle injury.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I currently have a deep vein blood clot.
Select...
I have skin issues or infections on my weak leg.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline to: post-6 weeks of training, and 6 weeks after completion of training
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to: post-6 weeks of training, and 6 weeks after completion of training
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Ankle
Ankle inversion-eversion range of motion
Gait
+3 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Seated Ankle Robot TrainingExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Baltimore VA Medical CenterLead Sponsor
32 Previous Clinical Trials
2,995 Total Patients Enrolled
Charlene E. Hafer-Macko, M.D.Principal InvestigatorBaltimore VA Medical Center
1 Previous Clinical Trials
100 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have chronic foot drop and ankle weakness in one leg due to a nerve or muscle injury.I have no health issues preventing me from sitting and using a rehabilitation robot.I am between 18 and 88 years old.I can walk 10 meters and get up from a chair by myself, but I may use devices like a cane.I currently have a deep vein blood clot.I have skin issues or infections on my weak leg.I am currently in a physical therapy or orthopedic program.
Research Study Groups:
This trial has the following groups:- Group 1: Seated Ankle Robot Training
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.